Literature DB >> 12068199

Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.

M Duffy1, L O'Mahony, J C Coffey, J K Collins, F Shanahan, H P Redmond, W O Kirwan.   

Abstract

PURPOSE: Ileal pouch-anal anastomosis remains the "gold standard" in surgical treatment of ulcerative colitis and familial adenomatous polyposis. Pouchitis occurs mainly in patients with a background of ulcerative colitis, although the reasons for this are unknown. The aim of this study was to characterize differences in pouch bacterial populations between ulcerative colitis and familial adenomatous pouches.
METHODS: After ethical approval was obtained, fresh stool samples were collected from patients with ulcerative colitis pouches (n = 10), familial adenomatous polyposis (n = 7) pouches, and ulcerative colitis ileostomies (n = 8). Quantitative measurements of aerobic and anaerobic bacteria were performed.
RESULTS: Sulfate-reducing bacteria were isolated from 80 percent (n = 8) of ulcerative colitis pouches. Sulfate-reducing bacteria were absent from familial adenomatous polyposis pouches and also from ulcerative colitis ileostomy effluent. Pouch Lactobacilli, Bifidobacterium, Bacteroides sp, and Clostridium perfringens counts were increased relative to ileostomy counts in patients with ulcerative colitis. Total pouch enterococci and coliform counts were also increased relative to ileostomy levels. There were no significant quantitative or qualitative differences between pouch types when these bacteria were evaluated.
CONCLUSIONS: Sulfate-reducing bacteria are exclusive to patients with a background of ulcerative colitis. Not all ulcerative colitis pouches harbor sulfate-reducing bacteria because two ulcerative colitis pouches in this study were free of the latter. They are not present in familial adenomatous polyposis pouches or in ileostomy effluent collected from patients with ulcerative colitis. Total bacterial counts increase in ulcerative colitis pouches after stoma closure. Levels of Lactobacilli, Bifidobacterium, Bacteroides sp, Clostridium perfringens, enterococci, and coliforms were similar in both pouch groups. Because sulfate-reducing bacteria are specific to ulcerative colitis pouches, they may play a role in the pathogenesis of pouchitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12068199     DOI: 10.1007/s10350-004-6187-z

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  38 in total

1.  A shift from colon- to ileum-predominant bacteria in ileal-pouch feces following total proctocolectomy.

Authors:  Manami Hinata; Atsushi Kohyama; Hitoshi Ogawa; Sho Haneda; Kazuhiro Watanabe; Hideyuki Suzuki; Chikashi Shibata; Yuji Funayama; Ken-Ichi Takahashi; Iwao Sasaki; Kouhei Fukushima
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

Review 2.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

Review 3.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

4.  Understanding the pouch microbiota: an evolving story.

Authors:  Laura Harrell Raffals
Journal:  Dig Dis Sci       Date:  2012-11       Impact factor: 3.199

5.  Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India.

Authors:  Ravi Verma; Anil Kumar Verma; Vineet Ahuja; Jaishree Paul
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

6.  The bacterial pathogenesis and treatment of pouchitis.

Authors:  S D McLaughlin; S K Clark; P P Tekkis; R J Nicholls; P J Ciclitira
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

7.  Real-time molecular monitoring of chemical environment in obligate anaerobes during oxygen adaptive response.

Authors:  Hoi-Ying N Holman; Eleanor Wozei; Zhang Lin; Luis R Comolli; David A Ball; Sharon Borglin; Matthew W Fields; Terry C Hazen; Kenneth H Downing
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

8.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 9.  Hydrogen sulfide signaling in the gastrointestinal tract.

Authors:  David R Linden
Journal:  Antioxid Redox Signal       Date:  2013-05-19       Impact factor: 8.401

10.  Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis.

Authors:  Lisa S Poritz; Rishabh Sehgal; Arthur S Berg; Lacee Laufenberg; Christine Choi; Emmanuelle D Williams
Journal:  J Gastrointest Surg       Date:  2013-03-27       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.